© John Wiley & Sons Ltd
Editors-in-Chief: Oliver Keene, Thomas Permutt and Gerd Rosenkranz
Impact Factor: 0.833
ISI Journal Citation Reports © Ranking: 2014: 65/122 (Statistics & Probability); 222/254 (Pharmacology & Pharmacy)
Online ISSN: 1539-1612
Welcome to the new Editor-in-Chief
We are delighted to welcome Tom Permutt as one of three Editors-in-Chief of Pharmaceutical Statistics.
Tom Permutt supervises the statisticians at FDA working on analgesic, pulmonary, and endocrine drugs. He was among the first to apply methods of causal inference, which he had learned by way of econometrics, to questions in biostatistics. He has been interested in the missing data problem since 1975, when he spent a summer at the Census Bureau phoning farmers who hadn’t filled out their census forms.
Tom joins existing editors Oliver Keene and Gerd Rosenkranz in the role.
Recently Published Articles
- Adaptive truncated weighting for improving marginal structural model estimation of treatment effects informally censored by subsequent therapy
Xiaofei Bai, Jingyi Liu, Li Li and Douglas Faries
Article first published online: 5 OCT 2015 | DOI: 10.1002/pst.1719
- Model free audit methodology for bias evaluation of tumour progression in oncology
Andrew Stone, Euan Macpherson, Ann Smith and Christopher Jennison
Article first published online: 5 OCT 2015 | DOI: 10.1002/pst.1707
- Sample size planning for phase II trials based on success probabilities for phase III
Heiko Götte, Armin Schüler, Marietta Kirchner and Meinhard Kieser
Article first published online: 28 SEP 2015 | DOI: 10.1002/pst.1717
- Bayesian adaptive dose-escalation procedures for binary and continuous responses utilizing a gain function
Wai Yin Yeung, John Whitehead, Bruno Reigner, Ulrich Beyer, Cheikh Diack and Thomas Jaki
Article first published online: 9 SEP 2015 | DOI: 10.1002/pst.1706